Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery
- Type of Study
- Cancer (Oncology) - Endometrial
- Location
- Swedish Cancer Institute
- Short Description
Purpose: The main purpose of the study is to evaluate the detection rate and accuracy of fluorescence imaging in endometrial cancer staging by sentinel node assessment.
- Status
- Open to Enrollment
- Principal Investigator
- Pamela Paley, M.D.
- Eligibility Notes
- Must have planned to undergo standard endometrial cancer staging surgery as part of their routine clinical care
- No significant liver disease, cirrhosis or liver insufficiency with abnormal liver function tests, with total bilirubin > 1.5 times normal, and/or SGOT > 2 times normal
- No uremia, serum creatinine > 2.0 mg/dl
- No previous history of adverse reaction or allergy to ICG dye, iodine, shellfish, or iodine dyes
- No previous lymphadenectomy or surgery that could change the uterine lymphatic drainage
- More Info Link
- Additional information about the study summary and eligibility criteria may be viewed on the U.S. National Institutes of Health (NIH) website.
- Contact Name
- Pamela Paley, M.D.
- Phone
- (206) 965-1700
- ppaley@pacificgyn.com
